MetLife Investment Management’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $131K | Buy |
60,010
+9
| +0% | +$20 | ﹤0.01% | 2404 |
|
|
2025
Q1 | $164K | Sell |
60,001
-982
| -2% | -$2.68K | ﹤0.01% | 2301 |
|
|
2024
Q4 | $254K | Hold |
60,983
| – | – | ﹤0.01% | 2177 |
|
|
2024
Q3 | $237K | Hold |
60,983
| – | – | ﹤0.01% | 2200 |
|
|
2024
Q2 | $239K | Buy |
60,983
+13,315
| +28% | +$52.2K | ﹤0.01% | 2136 |
|
|
2024
Q1 | $200K | Hold |
47,668
| – | – | ﹤0.01% | 2203 |
|
|
2023
Q4 | $224K | Hold |
47,668
| – | – | ﹤0.01% | 2178 |
|
|
2023
Q3 | $149K | Hold |
47,668
| – | – | ﹤0.01% | 2366 |
|
|
2023
Q2 | $219K | Sell |
47,668
-8,456
| -15% | -$38.8K | ﹤0.01% | 2215 |
|
|
2023
Q1 | $278K | Hold |
56,124
| – | – | ﹤0.01% | 2014 |
|
|
2022
Q4 | $306K | Hold |
56,124
| – | – | ﹤0.01% | 1970 |
|
|
2022
Q3 | $365K | Hold |
56,124
| – | – | ﹤0.01% | 1869 |
|
|
2022
Q2 | $265K | Hold |
56,124
| – | – | ﹤0.01% | 2113 |
|
|
2022
Q1 | $392K | Buy |
56,124
+20,012
| +55% | +$140K | ﹤0.01% | 1931 |
|
|
2021
Q4 | $368K | Buy |
+36,112
| New | +$368K | ﹤0.01% | 1673 |
|